Writing my own virtualized loader is something I’ve been wanting to do since I first read Microsoft’s deep dive on FinFisher’s multi-layered VM obfuscation back in 2018. FinFisher didn’t just use one ...
Bit Origin (BTOG) on Thursday announced a 1-for-60 reverse stock split, effective January 20, 2026. "The reverse stock split is intended to support our efforts to maintain compliance with Nasdaq’s ...
LOS ANGELES--(BUSINESS WIRE)--Creative Media & Community Trust Corporation (NASDAQ: CMCT) (“we”, “our”, “CMCT” or the “Company”) announced today that its Board of Directors has approved a reverse ...
Bitcoin BTC $60,772.24 treasury firm Nakamoto (NAKA) is resorting to a familiar Wall Street playbook as it looks to lift its beating-down share price and stay on Nasdaq. The company is seeking ...
Mobix Labs’s Common Stock is Expected to Begin Trading on a Post-Split Adjusted Basis on April 7, 2026 Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”), a rapidly growing fabless semiconductor and ...
FuboTV (NYSE:FUBO) stock is down Tuesday as the company’s officially scheduled reverse stock split ignites a sharp debate among retail investors about whether the move signals a turnaround or a ...
Distance is important for your tee shots, but all those yards are worthless if you can’t keep the ball in play. That’s why spurning accuracy in the pursuit of distance is such a dangerous game. You ...
Materials maker DuPont plans to ask shareholders to approve a reverse stock split that could reduce its share count by as much as 75%. If the measure is approved at the company's May 21 annual meeting ...
DuPont de Nemours DD announced its plan for a reverse split of the company’s common stock between 1-for-2 and 1-for-4 shares. Management will put up the proposal for a shareholder vote at its upcoming ...
DuPont (DD) said post-market Wednesday it plans to seek stockholder approval for a reverse stock split that could reduce its share count by as much as 75%. The company said it will seek approval of ...
SOLANA BEACH, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating ...